TY - JOUR
T1 - Long-term effect of low frequency stimulation of STN on dysphagia, freezing of gait and other motor symptoms in PD
AU - Xie, Tao
AU - Bloom, Lisa
AU - Padmanaban, Mahesh
AU - Bertacchi, Breanna
AU - Kang, Wenjun
AU - Maccracken, Ellen
AU - Dachman, Abraham
AU - Vigil, Julie
AU - Satzer, David
AU - Zadikoff, Cindy
AU - Markopoulou, Katerina
AU - Warnke, Peter
AU - Kang, Un Jung
N1 - Funding Information:
Funding This study had a grant support by the Michael J. Fox Foundation for parkinson’s Disease under the Rapid Response Innovation award (extension) to TX.
Publisher Copyright:
© Article author(s) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.
PY - 2018/9/1
Y1 - 2018/9/1
N2 - Objective To evaluate the long-term effect of 60 Hz stimulation of the subthalamic nucleus (STN) on dysphagia, freezing of gait (FOG) and other motor symptoms in patients with Parkinson's disease (PD) who have FOG at the usual 130 Hz stimulation. Methods This is a prospective, sequence randomised, crossover, double-blind study. PD patients with medication refractory FOG at 130 Hz stimulation of the STN were randomised to the sequences of 130 Hz, 60 Hz or deep brain stimulation off to assess swallowing function (videofluoroscopic evaluation and swallowing questionnaire), FOG severity (stand-walk-sit test and FOG questionnaire) and motor function (Unified PD Rating Scale, Part III motor examination (UPDRS-III)) at initial visit (V1) and follow-up visit (V2, after being on 60 Hz stimulation for an average of 14.5 months), in their usual medications on state. The frequency of aspiration events, perceived swallowing difficulty and FOG severity at 60 Hz compared with 130 Hz stimulation at V2, and their corresponding changes at V2 compared with V1 at 60 Hz were set as primary outcomes, with similar comparisons in UPDRS-III and its subscores as secondary outcomes. Results All 11 enrolled participants completed V1 and 10 completed V2. We found the benefits of 60 Hz stimulation compared with 130 Hz in reducing aspiration frequency, perceived swallowing difficulty, FOG severity, bradykinesia and overall axial and motor symptoms at V1 and persistent benefits on all of them except dysphagia at V2, with overall decreasing efficacy when comparing V2 to V1. Conclusions The 60 Hz stimulation, when compared with 130 Hz, has long-term benefits on reducing FOG, bradykinesia and overall axial and motor symptoms except dysphagia, although the overall benefits decrease with long-term use. Clinical trial registration NCT02549859; Pre-results.
AB - Objective To evaluate the long-term effect of 60 Hz stimulation of the subthalamic nucleus (STN) on dysphagia, freezing of gait (FOG) and other motor symptoms in patients with Parkinson's disease (PD) who have FOG at the usual 130 Hz stimulation. Methods This is a prospective, sequence randomised, crossover, double-blind study. PD patients with medication refractory FOG at 130 Hz stimulation of the STN were randomised to the sequences of 130 Hz, 60 Hz or deep brain stimulation off to assess swallowing function (videofluoroscopic evaluation and swallowing questionnaire), FOG severity (stand-walk-sit test and FOG questionnaire) and motor function (Unified PD Rating Scale, Part III motor examination (UPDRS-III)) at initial visit (V1) and follow-up visit (V2, after being on 60 Hz stimulation for an average of 14.5 months), in their usual medications on state. The frequency of aspiration events, perceived swallowing difficulty and FOG severity at 60 Hz compared with 130 Hz stimulation at V2, and their corresponding changes at V2 compared with V1 at 60 Hz were set as primary outcomes, with similar comparisons in UPDRS-III and its subscores as secondary outcomes. Results All 11 enrolled participants completed V1 and 10 completed V2. We found the benefits of 60 Hz stimulation compared with 130 Hz in reducing aspiration frequency, perceived swallowing difficulty, FOG severity, bradykinesia and overall axial and motor symptoms at V1 and persistent benefits on all of them except dysphagia at V2, with overall decreasing efficacy when comparing V2 to V1. Conclusions The 60 Hz stimulation, when compared with 130 Hz, has long-term benefits on reducing FOG, bradykinesia and overall axial and motor symptoms except dysphagia, although the overall benefits decrease with long-term use. Clinical trial registration NCT02549859; Pre-results.
KW - DBS
KW - Parkinson's disease
KW - STN
KW - dysphagia
KW - freezing
KW - frequency
KW - gait
UR - http://www.scopus.com/inward/record.url?scp=85049048067&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85049048067&partnerID=8YFLogxK
U2 - 10.1136/jnnp-2018-318060
DO - 10.1136/jnnp-2018-318060
M3 - Article
C2 - 29654112
AN - SCOPUS:85049048067
SN - 0022-3050
VL - 89
SP - 989
EP - 994
JO - Journal of Neurology, Neurosurgery and Psychiatry
JF - Journal of Neurology, Neurosurgery and Psychiatry
IS - 9
ER -